HAS2 and non-small cell lung carcinoma: However loss of HAS2 predominantly slowed down the proliferation of the AGL knockdown NSCLC cell lines (Figure 4E, 4F) even though HA synthesis was inhibited in both the control (shCTL) and the AGL knockdown cells (shAGL) with loss of HAS2 (Figure 4C, 4D).